1. Clinical significance of biological markers. The Memorial Hospital experience;Barzell;Seminars in Oncology,1979
2. Cis-diaminodichloro-platinum, vinblastine and bleomycin combined chemotherapy in disseminated testicular cancer;Einhorn;Annals of Internal Medicine,1977
3. Evaluation of computed tomography in the management of testicular teratoma;Husband;British Journal of Urology,1981
4. Expectant therapy for clinical stage A nonseminomatous germ-cell testicular cancer'? Maybe;Jewett;World Journal of Urology,1984
5. Klepp, O. , Fosså, S. , Fritjofsson, , Herikson, H. , Maarman-Moe, H. , Persson, B. E. , Ranstam, J. and Wicklund, H. , For the SWENOTECA Study Group (1985). Risk factors for metastases in clinical stage I nonseminomatous germ cell testicular cancer. Abstracts ECCO 3. P. 56. Abstract 200, Stockholm.